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ABSTRACT 
BACKGROUND: Urinary tract infections (UTI’s) are among the commonest bacterial infectious disease in clinical practice with 
a wide range of etiologic agents. It frequently occurs in both the hospital and the community.                                            
AIMS/OBJECTIVES:: To determine the etiology of UTI at BUTH and obtain data on their susceptibility and resistance patterns. 
METHODS: This was a prospective analysis of data on patients with UTI obtained from in and outpatients over a six month 
period. Samples had been obtained by clean catch mid-stream urine or suprapubic aspiration. The organisms had been 
identified by biochemical methods with susceptibility and resistance testing performed. Data analysis was with EPI-INFO 
version 3.5.1                                                                                                                             
RESULTS: There were a total of 200 urine samples that had positive growth. Prevalent organisms were Escherichia coli (48%) 
and Klebsiellaspp (24%), followed by Staphylococcus aureus (10%) and Coagulase Negative Staphylococci (6.5%). The risk 
factors for UTI were female gender (p = 0.00), Diabetes mellitus (p = 0.03) and genitourinary surgery (p = 0.04). Effective 
antibiotics in-vitro to Escherichia coliwere Nitrofurantoin and Cefepime at 84.8% and 92.3% respectively; while Cotrimoxazole 
performed poorly (32.5% susceptibility).                                                                                                                             
CONCLUSION: Urinary tract infections are an important cause of morbidity in our environment and inaccuracies in diagnosis 
will prolong morbidity and may lead to costly and unsafe treatments.The prevalent pathogens in our environment are the Gram 
negative bacilli, Escherichia coli and Klebsiellapneumoneae. Nitrofurantoin retains efficacy to both urinary pathogens. 
KEY WORDS: Urinary Tract Infection, Catheterization, Escherichia coli, Risk factors, Nitrofurantoin 
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RESUME                                                                                                                                                                                                               
CONTEXTE : Les infections urinaires (UTI) sont parmi les maladies infectieuses bactériennes les plus courantes dans la 
pratique clinique avec une large gamme d’agents étiologiques. Il se produit fréquemment dans l’hôpital et la communauté. 
OBJECTIFS : Pour déterminer l’étiologie de UTI à BUTH et obtenir des données sur les modelés de leurs susceptibilités et 
résistances.                                                                                                                                                                                                                       
METHODES : Il s’agissait d’une analyse prospective des données sur les patients atteints de UTI obtenue des patients en 
hospitalisation et externes d’unpériode de six mois. Des échantillons ont été obtenus par prélèvement propre àl’urine moyenne 
ou par aspiration supra pubienne. Les organismes ont été identifiés par des méthodes biochimiques avec des tests de sensibilité 
et de résistance effectués. L’analyse des donnéesétait avec EPI – INFO version 3.5.1                                                                  
RESULTATS : Il y avait un total de 200 échantillons d’urine qui avaient une croissance positive. Les organismes 
prédominantsétaientEscherichia coli (48%) et Klebsiella spp (24%), suivi de Staphylococcus aureus (10%) et Coagulase 




chirurgie génito – urinaire (p= 0,04). Des antibiotiques efficaces in vitro pour Escherichia coli étaient la Nitrofurantoïne et le 
cefépime à 84,8%  et 92,3% respectivement ; tandis que le cotrimoxazole a présenté un mauvais rendement (susceptibilité de 
32,5%).                                                                                                                                                                                                             
CONCLUSION: Les infections des voies urinaires sont une cause importante de morbidité dans notre environnement et les 
inexactement dans le diagnostic plongera la morbidité et peut conduire à des traitements coûteux et dangereux. Les pathogènes 
prédominants dans notre environnement sont les bacilles Gram négatif, Escherichiacoli et Klebsiellapneumoniae. Le 
Nitrofurantoïne conserve son efficacité pour les deux pathogènes urinaires. 
MOTS – CLÉS: L’infection des voies urinaires, Cathétérisme, Escherichia coli, Les facteurs de risque, Nitrofurantoïne. 
INTRODUCTION                                                                   
Urinary tract infections (UTI’s) are among the 
commonest bacterial infectious disease in clinical 
practice with a high rate of morbidity. They are 
described as bacteriuria associated with or without 
urinary symptoms and are exceeded in frequency 
among ambulatory patients only by respiratory and 
gastrointestinal infections. It is the second most 
common infectious presentation in community 
practice and over 150 million people are diagnosed 
with UTI each year, with economic implications [1, 2, 
3, 4]. 
The urinary tract is usually sterile, but bacteria may 
rise from the peri anal region, possibly leading to UTI 
in what is typically described as an ascending 
infection. Pathogens in the bladder may stay silent or 
can cause irritating symptoms like urinary frequency 
and urgency. UTI’s are associated with sequelae such 
as renal scarring, pyelonephritis, renal and failure and 
as such need to be accurately diagnosed. In the light 
of antimicrobial resistance it is also vital that 
susceptibility results are reliable and accurate for the 
use of the clinician in the management of the patient. 
Females bear the higher burden of UTI than males 
and are more likely to experience UTI than men. 
Nearly one in three women will have had at least an 
episode of UTI requiring antimicrobial therapy by the 
age of 24 years. In addition about fifty percent of all 
women will experience one UTI during their lifetime. 
Those at increased risk of UTI include infants, 
pregnant women, the elderly, patients with spinal 
cord injuries and/or those catheterized, patients with 
diabetes mellitus, patients who are immune-deficient, 
and patients with underlying urologic 
abnormalities[5]. 
Among women 18–30 years old, the incidence of 
acute uncomplicated urinary tract infections (UTIs) is 
estimated to exceed 0.5 episodes per annum. These 
infections are a major source of morbidity and health 
care costs in this population. Identified risk factors for 
such infections include sexual activity, spermicide-
based contraception, and a history of previous 
UTIs[6]. 
The etiology of UTI is also affected byother 
underlying host factors that complicate UTI, such as 
age (the extremes of life), diabetes mellitus, spinal 
cord injury, or catheterization. Consequently, 
complicated UTI has a more diverse etiology than 
uncomplicated UTI, and organisms that often do not 
cause disease in healthy patients can cause significant 
disease in hosts with anatomic anomalies, metabolic 
derangements or immunologic compromise. The 
pathogens associated with UTI are changing the way 
they present in infections due to antimicrobial 
resistance [7]. 
There is the need to know the pattern of presentation 
of UTI’s in our local practice as this would aid 
clinicians in the management of such patients. In 
addition few studies have been conducted in our local 
environment to understand the risk factors for the 
acquisition of UTI’s as well as the picture as it 
pertains to resistance with first-line agents among 
patients with acute uncomplicated UTI.  
The diagnosis may not always be straightforward as it 
may mimic other clinical conditions including an 
acute abdomen. Physicians therefore need accurate 
laboratory support in order to distinguish it from 
other diseases that have a similar clinical presentation 
as some UTIs are asymptomatic or present with 
atypical signs and symptoms. 
AIM: To obtain data on etiology of UTI and their 
susceptibility patterns as well as the risk factors. 
OBJECTIVES: To assess the in-vitro efficacy of 
antibiotics towards the pathogens responsible for UTI 
in BUTH and to determine the microbial pathogens 
causing UTI’s at the Babcock University Teaching 
Hospital 
MATERIALS AND METHODS                                        
Study site/design/population: the study site was the 
Medical Microbiology Department of the Babcock 
University teaching Hospital, a 140 bed facility 
located in Ilisan South West Nigeria.; This is a 
retrospective study of data focusing on the frequency 
of uro-pathogens and their antibiotic susceptibility in 
different gender and age groups of patients and data 
from December 2015 – April 2016 were analyzed. The 
study population consisted of patients from ages One 
to Ninety Nine years, with suspected UTI being 
treated in the inpatient department or an outpatient 




were referred because of urinary symptoms such as 
dysuria or unexplained acute febrile illness. 
Demographic data, epidemiological factors, and 
antibiotic susceptibility of pathogens were obtained 
from patient records.  
Sample Collection: urine specimens had been 
previously obtained from adult patients via the clean-
catch midstream technique.UTI was defined as the 
growth of a single pathogen of >105 colony forming 
units/ml by properly collected urine specimen 
(suprapubic aspiration, catheterization, or midstream 
specimen) in patients with urinary symptoms.  
Sample Size: The average isolation rate of organisms 
from urine is approximately 15%, using the Kish 
formula this gives a sample size of 200 patients.   
Antimicrobial Susceptibility Testing: This was done 
on Mueller- Hinton agar (Oxoid UK) using disk 
diffusion (Kirby Bauer's) technique. This method was 
done according to Clinical and Laboratory Standards 
Institute (CLSI) guidelines to determine susceptibility 
of UTIs agents [8]. 
Isolates with intermediate resistance were grouped 
with resistant isolates in the analysis. The antibiotic 
disks (Oxoid UK) comprised of ampicillin (10µg), 
ciprofloxacin (5µg), nitofurantoin (300µg), ceftriaxone 
(30µg), cefotaxime (10µg) and gentamicin (10µg), 
cefepimeand trimethoprim-sulfamethoxazole (25µg), 
cefepime (30µg), cefuroxime (30µg), cefpodoxime 
(30µg), ceftazidime (30µg), meropenem (30µg), 
ampicillin-sulbacatam (30µg), cefoxitin(30µg), co-
amoxiclav (25µg). 
Antimicrobial resistance for extended spectrum beta 
lactamases was determined by the double disk 
diffusion method where a Co-Amoxiclav disc was 
placed 20 mm centre to centre in between a 
Ceftazidime and Ceftriaxone disc. A dumb bell 
appearance or distortion on the side facing the Co-
Amoxiclav was a phenotypic indicator of ESBL 
expression. MRSA – Methicillin Resistant 
Staphylococcus aureus were detected by using a 
Cefoxitin30µg disc as a surrogate marker, a zone size 
less than 20 mm was indicative of Methicillin 
resistance.  
Data Analysis: EPI INFO version 3.5.1 was used to 
detect significant differences between the age groups 
and the prescribed treatment, the bacteriological 
culture results and the antimicrobial susceptibility of 
the isolates. A P value of <0.05 was considered 
statistically significant.Statistical analysis was 
performed with Pearson’s χ2 test as well as Fisher’s 
exact test and odds ratio for categorical 
variables.Informed Consent: consent is implied to 
have been given during the course of specimen 
analysis. Ethical Issues: ethical approval was sought 
and obtained from the Babcock University Human 
Research Ethics Committee – BUHREC. 
RESULTS                                                                                     
In all, there were 200 patients records recruited into 
the study. The mean age of the participants in the 
study was 38.2 years (Standard deviation 20.86) with 
the patients ranging from ages 1 – 99. The male to 
female ratio was 0.27:1. In the study 20% (n = 32) of 
the 158 females were pregnant. Also 17% (n=33) were 
catheterized, 35% of patients were hospitalized (n=70) 
(Table 1). 





Gender Male   42 21 
 Female 158 79 
Pregnant Yes   32 20 
 No 126 80 
Pediatric Yes   21 10.5 
 No 179 89.5 
Elderly Yes   33 16.5 
 No 167 83.5 
Catheterized Yes   34 17 
 No 166 84 
Admission 
Status 
Inpatient   70 35 
 Outpatient 130 65 
Asymptomati
c Bacteriuria 
Present    32 16 




























Yes   10 5 
 No 190 95 
 No 198 99 
ESBL 
production 
Positive     8 4 
 Negative 192 96 
MRSA 
production 
Positive     4 2 
 Negative 196 98 






Present     6 3 
 Absent 194 97 
Diabetes 
Mellitus 
Positive     7 3.5 
 Negative 193 96.5 
Recurrent UTI Yes     5 2.5 
 No 195 97.5 
ESBL = Extended Spectrum Beta Lactamases, UTI – 
Urinary Tract Infection Mean age = 38.32 years, Range 1 - 
99 years, S.D = 20.86 
Asymptomatic bacteriuria was seen in 16% (n=32). 
Post-operative patients accounted for 5% of patients 
(n=10), the same percentage of patients had Benign 
Prostatic hypertrophy with 2 male patients presenting 
with testicular swellings. About 4% of patients (n=8) 
had an ESBL elaborating organism and 2% (n =4) 
harbored an MRSA strain in their urine. In addition 
49% (n=98) had a complicated UTI, while 
Pyelonephritis was recorded in 6% of patients (n=3). 
Diabetes mellitus was seen in 7 patients while 5 had a 
history of recurrent UTI, only one patient among the 
females presented with threatened abortion. 
The predominant pathogen in the urine of our 
patients was Escherichia coliaccounting for 48% (n=96) 
cases (Figure 1). This was followed by Klebsiellaspp 
with 24% (n=48) and Staphylococcus aureus 10.5% 
(n=21). Others isolated were Staphylococcus epidermidis 
6.5%, (n=13), Proteus spp 4.5% (n=9), Pseudomonas spp 
3.5% (n=7), Staphylococcus saprophyticus 2% (n=4) and 
Salmonella spp 1% (n=2).  
Three risk factors were identified and these were: 
gender as females were 0.4 times more likely to have 
an organism isolated from their urine in our center 
[O.R=0.4, 95% CI=0.2-0.8, χ2 = 6.64, p=0.00], diabetic 
patients who were 6.6 times more likely to have a UTI 
[O.R=6.6, 95% CI=0.8-55.7, χ2 = 3.9, p=0.03] and 
Postoperative patients [O.R=4..44, 95% CI= 1.0-21.5, χ2 


















TABLE 2 RISK FACTORS FOR ACQUISITION OF ESCHERICHIA COLI UTI 




Chi Square P value 
       
  Positive Negative     
Adults Yes 68 77 0.74 0.4 – 1.4 0.9 0.33 









1.22 0.6 – 2.6 0.26 0.61 
Gender Female 70 88 0.4 0.2-0.8 6.64 0.00 
 Male 28 14     
Type of UTI Complicated 53 45 1.5 0.9-2.6 1.99 0.16 
 Uncomplicated 45 57     






6.6 0.8 – 55.7 3.9 0.03* 
Elderly Yes 21 12 2.05 0.95 – 4.43 3.39 0.06 
 No 77 99     
Admission status In-patient 38 32 1.39 0.77 – 2.48 1.20 0.27 
 Outpatient 60 70     
Postoperative Yes 8 2 4.44 1.0 – 21.5 4.05 0.04* 
 No 90 100     
Pregnant Yes 11 21 0.49 0.22 – 1.07 3.26 0.07 
 No 87 81     




The rates of susceptibility by Escherichia was seen 
with Nitrofurantoin and Cefepime 84.8% and 92.3% 
highest respectively followed by Genticin, 
Ceftriaxone, Cefpdoxime and Co-Amoxiclav,  71.8%, 
70,8%, 70.6% and 68.4% respectively. 
Ampicillin/Sulbactam and Cotrimoxazole displayed 
the lowest rates of susceptibility – 23.9% and 20.7% 
each (Table 3). 
TABLE 3 ANTIMICROBIAL SUSCEPTIBILITY PATTERN 







Augmentin 68.4 31.6 0.00 
Cefepime 92.3 7.7 0.16 
Cefpodoxime 70.6 29.4 0.79 
Ceftazidime 69.5 30.5 0.78 
Ceftriaxone 70.8 29.2 0.83 
Cefuroxime 57 43 0.82 
Ciprofloxacin 39.5 60.5 0.00 
Cotrimoxazole 20.7 79.3 0.94 
Genticin 71.8 28.2 0.40 
Nitrofurantoin 84.8 15.2 0.00 
Ampicillin/Sulbactam 23.9 76.1 0.23 
Piperacilin/Tazobactam 52.0 48.0 0.20 
 
Linear regression analysis showed that with 
decreasing age there was a higher likelihood of 
isolating the following organisms Klebsiellaspp. p=0.01, 
Proteus spp. p=0.03, Staphylococcus aureusp=0.00 and 
Staphylococcus saprophyticus.Whereas with increasing 
age the following was likely to be isolated, 
Pseudomonas sppp=0.00 and Escherichia colip=0.04 
(Table 4). 









Klebsiellaspp -8.53 3.43 6.20 0.01 
Proteus spp -15.05 6.76 4.96 0.03 
Pseudomonas 
spp 
21.85 7.59 8.29 0.00 
Salmonella spp -19.22 13.85 1.93 0.17 
Staphylococcus 
aureus  
-15.43 4.67 10.92 0.00 
Staphylococcus 
epidermidis 
-8.72 5.94 2.16 0.14 
Staphylococcus 
saprophyticus 
-16.47 9.89 2.77 0.01 
Escherichia coli   8.40                 2.89       8.40        0.04 
DISCUSSION                                                                       
Urinary tract infections are prevalent in clinical 
practice both in in-patients and out patients. In our 
facility urine samples for microscopy culture and 
susceptibility are among the most frequently 
requested tests. Most physicians will attend to cases 
of UTI often in their routine health care practice. They 
are also one of the most frequent clinical bacterial 
infections in women, accounting for nearly 25% of all 
infections. Around 50–60% of women will experience 
an episode in their lifetime [9]. 
We report a rate of asymptomatic bacteriuria in 10% 
of our patients similar to those of some studies that 
reported 8% of patients having asymptomatic 
bacteriuria.We also report a higher frequency of UTI’s 
in females,which is the norm in literature due to the 
anatomic differences of male and female genito-
urinary tracts. Prior studies showed that one in three 
females will have at least one symptomatic UTI 
necessitating antibiotic treatment by the age of twenty 
four [10].  One of the possible reasons for repeated 
episodes in females could be due to errors in 
processing urine samples, thereby reporting 
commensals as pathogens. In addition urine samples 




not being educated on specimen collection by the 
physician. The young and sexually active tend to 
come down with it often, but it is also seen in elderly, 
postmenopausal women. The likelihood of recurrence 
is also high in patients who have had a previous 
episode of a UTI[11]. 
We found the following to be significant risk factors 
for UTI – female gender, the presence of diabetes 
mellitus and post-operative states. Clinicians in 
concert with the laboratory therefore need to have a 
heightened sense of awareness when dealing with 
urine samples from these patients. 
The pathogens causing UTI are consistent across the 
globe. We report a preponderance of Escherichia coli, 
followed by Klebsiellaspp and Staphylococcus aureus. 
These findings also mirror those of other studies 
showing that the microbial ecology of urinary 
pathogens has largely remained the same. [12] 
Enteric bacteria (in particular, Escherichia coli) have 
been and remain the most frequent cause of UTI, 
although there is some evidence in certain reports 
that the percentage of UTIs caused by E. coli is 
decreasing this does not appear to be the scenario in 
our hospital.  A different study from ours showed the 
percentage of UTIs caused by E. coli, Proteus species, 
and Pseudomonas species decreasing, whereas the 
percentage of UTIs caused by yeasts, group B 
streptococci, and Klebsiella pneumoneae increased [13]. 
A retrospective analysis of UTI at Jos in Nigeria by 
Jombo et al, revealed that the commonest pathogens 
in outpatients was Escherichia coli, while in in-patients 
it was Klebsiella spp, with the Quinolones and 
Cefuroxime the most effective antibiotics in-vitro[14]. 
Other pathogens such as Pseudomonas spp and Proteus 
spp are often recovered from patients who are 
catheterized. Pseudomonas aeruginosa is an 
opportunistic human pathogen that is especially 
adept at forming surface-associated biofilms. It causes 
catheter-associated urinary tract infections (CAUTIs) 
through biofilm formation on the surface of 
indwelling catheters and it has high rates of 
therapeutic failure[15]. 
Catheter-associated UTI is the most common 
nosocomial infection, accounting for over a million 
cases in hospitals. The catheterization rate from our 
study was 34% which happens to be less than that 
reported by similar centers which report figures as 
high as 54%. The risk of UTI increases with increasing 
duration of catheterization. In non-institutionalized 
elderly populations, UTIs are the second most 
common form of infection, accounting for nearly 25% 
of all infections [5, 16]. 
Catheter associated UTI also extends hospital stay 
and adds to the direct cost of acute care 
hospitalization. It is associated with increased 
mortality. A Study on Catheterization rates suggested 
that nosocomial CAUTI are associated with 
substantially increased mortality rates. It is therefore 
important to accurately define the local epidemiology 
of CA-UTI [17]. 
Complications may arise from UTI’s especiallyif 
bacteria enter the blood stream, they could cause 
severe complications, including septicemia, shock 
and, rarely, death. Conversely there may also be 
hematogenous spread of bacteria from the 
bloodstream into the kidney causing UTI’s in patients 
who are hospitalized, catheterized or who have 
undergone genitourinary surgery[8, 18, 19].                                 
In uncomplicated cases the infection is easily treated 
with a short course of an antibiotic, but in recent 
times there is increased resistance to many of these 
antibiotics resulting in treatment failure. 
Uncomplicated UTI should be distinguished from 
complicated UTI, which has a risk of severe illness 
and attendant effects such as renal scarring [20]. 
For the treatment of UTI’s the Physician should be 
guided by the results of diagnostic tests and recent 
antimicrobial susceptibility of urinary pathogens also 
because the microbiologic characteristics of acute, 
uncomplicated UTI are highly predictable in women, 
antimicrobial therapy is usually empiric. As a result 
of this a short-course (3-day) therapy is commonly 
used, however practices may vary with 
fluoroquinolones in non-pregnant females preferred 
by[21].  The Infectious Diseases Society of America 
(IDSA) advocates trimethoprim-sulfamethoxazole 
(SXT) as initial therapy for females with acute 
uncomplicated bacterial cystitis in settings where the 
prevalence of SXT resistance does not exceed 10 to 
20%.Our figure is 79.3% which is quite high. This 
guideline may not be suitable for Nigeria. Reports 
from elsewhere show that the resistance rates to SXT 
is unacceptably high and organisms such as 
Enterococcus spp are intrinsically resistant to it [22]. 
Other alternatives for short term therapy of UTI’s 
include the use of Trimethoprim or Nitrofurantoin 
which were successful in over 80% of the cases. 
Nitrofurantoin appears to still retain high success 
rates even in this era of increasing antimicrobial 
resistance as evidenced from the high rates of 
susceptibility by pathogens. Cotrimoxazole on the 
other hand has disappointingly low rates of 
susceptibility and in some centers. Cotrimoxazole is 
not considered a first-choice drug for UTI [22]. 
Patients with frequent urinary tract infection ought to 




patient-initiated, post-coital, or long-term low-dose 
therapy. Females with recurrent urinary tract 
infection in pregnancy should be considered for long-
term antibiotic prophylaxis. In addition long term 
suppression of infection may include fiveday courses 
of β-lactams such as Co-Amoxiclav or Nitrofurantoin 
depending largely on local susceptibility patterns[22, 
23]. 
 CONCLUSION                                                                      
Urinary tract infections are important causes of 
morbidity in our environment; and care needs to be 
placed on the diagnosis and management of such 
infections. The prevalent pathogens in our 
environment are the Gram negative bacilli: Escherichia 
coli and Klebsiella pneumoneae. Nitrofurantoin however 
still retains efficacy to both Gram negative and 
positive organisms. 
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